PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $227,000 | -67.9% | 1,944 | -35.2% | 0.07% | -74.5% |
| Q1 2015 | $708,000 | +6.9% | 3,000 | -14.3% | 0.26% | -16.5% |
| Q4 2014 | $662,000 | -30.6% | 3,500 | -12.5% | 0.31% | -34.7% |
| Q3 2014 | $954,000 | +261.4% | 4,000 | 0.0% | 0.48% | +161.0% |
| Q2 2014 | $264,000 | -59.1% | 4,000 | -35.5% | 0.18% | -60.6% |
| Q1 2014 | $646,000 | -37.6% | 6,200 | -38.0% | 0.46% | +168.6% |
| Q4 2013 | $1,035,000 | – | 10,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |